A better way to invest in startups.
“The approval of SRP and SNAP in Israel and the appointment of Eli Moshe as GM, come at a very pivotal time for Surgical Theater,” said Moty Avisar, CEO and Co-Founder of Surgical Theater. “We are very excited to grow our global presence and have no doubt Mr. Moshe will be a great catalyst in accelerating that growth. Increasing numbers of surgeons across the world will be able to use this novel technology to advance the way they perform surgeries.”
Read more here.
Big news this past week as Zebra Medical Vision received FDA clearance for its AI-powered intracranial hemorrhage detection product, its second FDA approval in a month! Congrats to sugar reduction company DouxMatok on their $22M raise; OurCrowd is proud to take part in this effort to reduce the world’s sugar dependency. data.world is bringing data to the next level with its recent acquisition of Capsenta – read about it here, and find more top news below.
New in medical cannabis: Syqe Medical releases its first cannabis inhaler.
The latest on Intel and Israel: The reality of autonomous cars is beginning to feel closer as Intel’s Mobileye plans to launch a trial of robo-cabs next year in Israel. Intel has also announced its accelerator launch in Israel, which aims to give early-stage startups “a unique advantage in their quest to disrupt the future.”
Sweetch on the front lines of disease prevention: Getting healthy with tech.
Houston Texans star quarterback Deshaun Watson received an overview of the Israeli sport tech industry from Jon Medved, CEO of equity crowdfunding platform OurCrowd.
Read more here.
Israeli pharma-tech company Syqe Medical today announced the launch of the world’s first pharmaceutical-grade metered-dose cannabis inhaler in Israel.
Read more here.
Designed to work in real life, Sweetch’s artificial intelligence-powered behavioral intelligence engine converts millions of data points originating from the user’s smartphone and other connected devices into contextual, highly personalized, just-in-time, just-in-place recommendations.
Read more here.
Their June 20 evening itinerary began with a briefing about Israeli innovation from venture investing platform OurCrowd CEO Jon Medved on the roof of Jerusalem’s Tower of David Museum.
Read more here.
On the Tower of David Museum’s roof in Jerusalem Watson got a short briefing Thursday on Israeli high-tech from Jonathan Medved, the CEO of OurCrowd, a leading Israeli equity crowdfunding platform that has an investment fund for sports tech.
Read more here.
Israeli sugar reduction company DouxMatok has announced the completion of a $22 million financing round. DouxMatok has developed sugar that is sweeter than the existing sugar in the market, making it possible to reduce the amount of sugar in food.
Read more here.
![[Surgical Theater in Yahoo Finance] Surgical Theater Received Approval to Market the Surgical Navigation Advanced Platform (SNAP) and SuRgical Planner (SRP) Systems from the Israeli Ministry of Health](https://blog.ourcrowd.com/wp-content/uploads/2018/03/Yahoo_Finance_Logo_2013.png){kind=logo}
![[OurCrowd in The Jerusalem Post] NFL star Watson learns Israeli sports tech](https://blog.ourcrowd.com/wp-content/uploads/2017/10/Jerusalem-post.jpg)
![[Syqe in Globes] Syqe begins marketing medical cannabis inhaler](https://blog.ourcrowd.com/wp-content/uploads/2017/10/Globes-NEW.jpg)
![[OurCrowd in Israel21c] NFL quarterback Deshaun Watson falls in love with Israel](https://blog.ourcrowd.com/wp-content/uploads/2018/02/israel-21cNEW.jpg)
![[OurCrowd in The Times of Israel] NFL quarterback Deshaun Watson says he’s wowed by Israel](https://blog.ourcrowd.com/wp-content/uploads/2017/10/the-times-of-israel-NEW.jpg)